<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03647059</url>
  </required_header>
  <id_info>
    <org_study_id>SHLTQC-2</org_study_id>
    <nct_id>NCT03647059</nct_id>
  </id_info>
  <brief_title>Rapid Assessment of Donor Liver Quality</brief_title>
  <official_title>Real-time Noninvasive Assessment of Donor Liver Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims：

        1. Conduct multi-center, prospective and open research on liver quality assessment and
           establish LSCM liver quality assessment system

        2. Classification of liver quality grades by LSCM for different pathological conditions
           (steatosis, fibrosis, hepatocyte necrosis, etc.)

        3. Compare the specificity and sensitivity of LSCM evaluation results with the results of
           liver donor quality evaluation and intraoperative pathological biopsy results.

        4. LSCM classifies the quality of donor liver and compares the recovery of liver function
           on the first day after liver transplantation.

        5. LSCM grades the quality of donor liver and compares the long-term prognosis
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>4 Years</target_duration>
  <primary_outcome>
    <measure>LSCM examination results</measure>
    <time_frame>1 day</time_frame>
    <description>LSCM examination is focus on the detections of the hepatocyte nucleus and the micro structures(such as the micro-circulation、central vein and so on).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HE section staining pathological examination</measure>
    <time_frame>1 week</time_frame>
    <description>All of donor livers must be detected by HE section staining pathological examination and it is mainly focused on the detection of hepatocyte nucleus and the micro structures(such as the micro-circulation、central vein and so on).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical examinations</measure>
    <time_frame>1 week</time_frame>
    <description>Mainly focus on the examinations such as ALT、AST、LDH and so on.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Transplant; Failure, Liver</condition>
  <arm_group>
    <arm_group_label>LSCM examination</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>LSCM examination</intervention_name>
    <description>Cut a piece of donor liver and conduct the LSCM examination after staining fluorescein</description>
    <arm_group_label>LSCM examination</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      we just need to cut a little piece of donor liver to conduct a examination of Laser scanning
      Confocal Microscopy(LSCM)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All donor livers to be used for liver transplantations. Before transplant, the donor liver
        will be stored in the cold-UW solution in ice water. We just cut a piece of liver simple in
        the any place of donor liver, usually, we always cut a piece of liver simple from the edge
        of the donor liver.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All donor livers to be used for liver transplantations

        Exclusion Criteria:

          -  Exclusion of multiple organ transplantation

          -  Exclusion of detached transplantation and partial liver transplantation, etc.

          -  Removal of blood type incompatible patients for transplantation

          -  Exclusion of poor donor liver quality due to surgical technique (such as hepatic
             artery embolization) , portal vein thrombosis, etc.)

          -  Any form of substance abuse, mental illness or any disease that the investigator
             believes may interfere with the patient's understanding of the research requirements.

          -  Can not complete routine research follow-up, and other circumstances that the
             investigator believes are not suitable for the experiment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhong Lin, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhong Lin, Doctor</last_name>
    <phone>13917603139</phone>
    <email>fox2189@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Zhong Lin, doctor</last_name>
      <phone>18817592189</phone>
      <email>fox2189@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2018</study_first_posted>
  <last_update_submitted>August 22, 2018</last_update_submitted>
  <last_update_submitted_qc>August 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Lin Zhong</investigator_full_name>
    <investigator_title>Director of hepatobiliary surgery</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>positive IPD is available to other researchers</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

